SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A decent increase of about 40.19% in the sales to Rs. 11210.56 millions was observed for the quarter ended December 2025. The sales figure stood at Rs. 7996.92 millions during the year-ago period.Net Profit for the quarter ended December 2025 zoomed to 142.76% from Rs. 688.81 millions to Rs. 1672.13  millions.Operating profit for the quarter ended December 2025 rose to 2836.32 millions as compared to 1551.00 millions of corresponding quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 11210.56 7996.92 40.19 27597.41 20467.11 34.84 36611.00 26026.67 40.67
Other Income 705.80 811.22 -13.00 2162.79 1284.53 68.37 1747.64 2707.86 -35.46
PBIDT 2836.32 1551.00 82.87 6323.48 3178.14 98.97 6183.86 4438.24 39.33
Interest 0.66 2.16 -69.44 3.14 7.56 -58.47 9.36 16.96 -44.81
PBDT 2835.66 1548.84 83.08 6320.34 3170.58 99.34 6174.50 4421.28 39.65
Depreciation 832.61 688.80 20.88 2374.42 2027.29 17.12 2746.12 2670.78 2.82
PBT 2003.05 860.04 132.90 3945.92 1143.29 245.14 3428.38 1750.50 95.85
TAX 330.92 171.23 93.26 696.77 236.55 194.56 691.02 382.86 80.49
Deferred Tax 157.42 23.32 575.04 143.26 24.60 482.36 209.97 93.93 123.54
PAT 1672.13 688.81 142.76 3249.15 906.74 258.33 2737.36 1367.64 100.15
Equity 902.20 902.20 0.00 902.21 902.21 0.00 902.20 902.20 0.00
PBIDTM(%) 25.30 19.39 30.45 22.91 15.53 47.56 16.89 17.05 -0.95

Sharda Cropchem Share Price

1121.05 -14.45 (-1.27%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 646.15
PI Industries 3108.10
Bayer CropScience 4608.85
Sharda Cropchem 1121.05
Sumitomo Chemical 485.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×